NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
WednesdayMar 15, 2017 12:30 pm

Tecogen Inc. (NASDAQ: TGEN) Starts Presentation at 29th Annual Roth Conference

Tecogen (NASDAQ: TGEN) designs, manufactures and sells industrial and commercial cogeneration systems that produce electricity, hot water and air conditioning primarily in the United States, the United Kingdom, Mexico and Ireland. It offers InVerde 100, InVerde e+, CM-75, and CM-60 cogeneration units that supply electricity and hot water; chillers that provide air-conditioning and hot water under the TECOCHILL brand name; and water heaters under the Ilios brand. The company also provides long-term maintenance contracts, parts sales and turnkey installation services through a network of nine field service centers in California, the Midwest, and the Northeast. For more information, visit the…

Continue Reading

WednesdayMar 15, 2017 12:30 pm

Pyxis Tankers Inc. (NASDAQ: PXS) Starts Presentation at 29th Annual Roth Conference

Pyxis Tankers (NASDAQ: PXS) operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products such as naphtha, gasoline, jet fuel, kerosene, diesel and fuel oil, as well as other liquid bulk items including vegetable oils and organic chemicals. The company’s fleet comprises six double hull product tankers. Pyxis Tankers was founded in 2015 and is based in Maroussi, Greece. For more information, visit the company’s website at www.pyxistankers.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

Continue Reading

WednesdayMar 15, 2017 12:30 pm

Auxilio, Inc. (AUXO) Starts Presentation at 29th Annual ROTH Conference

Auxilio (OTCQB: AUXO) provides complete document workflow solutions and IT security services to healthcare organizations across the United States. The company has helped its clients save more than $80 million since 2004 by providing solutions which lower costs, improve operational efficiency and enhance security. Auxilio’s iPLATFORM, an intelligent workflow automation suite delivers a customer driven, vendor neutral approach to secure patient health information, reduce waste and drive additional savings opportunities. Auxilio serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices supporting over 280,000 caregivers. For more information, visit the…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

VolitionRX Ltd (NYSE: VNRX) Starts Presentation at 29th Annual Roth Conference

VolitionRX (NYSE: VNRX) is a clinical-stage life sciences company that focuses on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is involved in the development of 28 epigenetic NuQ blood assays based on its Nucleosomics biomarker discovery platform. It develops two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer by detecting nucleosomes containing specific histone variants. VolitionRX also develops 17 blood assays in the NuQ-M family to detect cancer by detecting nucleosomes containing…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

ImageWare Systems, Inc. (IWSY) Starts Presentation at 29th Annual ROTH Conference

ImageWare Systems (OTCQB: IWSY) is a developer of mobile and cloud-based identity management solutions, providing biometric authentication solutions for the enterprise. The company delivers next-generation biometrics as an interactive and scalable cloud-based solution. ImageWare brings together cloud and mobile technology to offer multi-factor authentication for smartphone users, mobile clients, and desktop devices. ImageWare's products support multi-modal biometric authentication including, but not limited to, face, voice, fingerprint, eye, DNA, and more. All can be combined with or used as replacements of authentication and access control tools, including tokens, digital certificates, passwords, and PINS, to provide the ultimate level of assurance, accountability,…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

COPsync, Inc. (NASDAQ: COYN) Starts Presentation at 29th Annual ROTH Conference

COPsync (NASDAQ: COYN) is a real-time law enforcement mobile data information system in the United States. It provides COPsync Network, a software service which enables patrol officers to collect, report, and share critical data in real-time at the point of incident and obtain instant access to various local, state, and federal law enforcement databases. The company’s COPsync Network service also enables officers to electronically write tickets; process DUI and other arrests; and document accidents and other incidents, as well as allows dispatchers and officers to send be on the lookout and other alerts of child kidnappings, robberies, car thefts, police…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) Starts Presentation at 29th Annual ROTH Conference

Adamis Pharmaceuticals (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. The company’s current specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis, APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease, and APC-2000 for the treatment of bronchospasms. The company’s U.S. Compounding, Inc. subsidiary provides prescription compounded medications, including compounded sterile preparations and non-sterile compounds, to patients, physician clinics, hospitals, surgery centers and other clients throughout most of the United States. USC’s product offerings broadly…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

Yield10 Bioscience (NASDAQ: YTEN) Starts Presentation at 29th Annual Roth Conference

Yield10 Bioscience (NASDAQ: YTEN) is an advanced biomaterials company that focuses on delivering sustainable solutions to the plastics industry. The company develops and commercializes technologies for the production of polymers and chemicals in microbes and plants. It produces a family of biopolymers found in nature called polyhydroxyalkanoates (PHA), which occur naturally in living organisms and are chemically similar to polyesters. Yield10’s bio-based polymeric modifiers for rigid, semi-rigid, and flexible polyvinyl chloride compounds are used in construction materials and medical applications; PHA coatings for paper and cardboard; marine biodegradable micro powders for use in cosmetics and personal care products; and PHA…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

Advanced Emissions Solutions, Inc. (NASDAQ: ADES) Starts Presentation at 29th Annual ROTH Conference

Advanced Emissions Solutions (NASDAQ: ADES) serves as the holding entity for a family of companies that provide emissions solutions to customers in the power generation and other industries. ADA-ES, Inc. is a wholly-owned subsidiary that provides emissions control solutions for coal-fired power generation and industrial boiler industries. With more than 25 years of experience developing advanced mercury control solutions, ADA delivers proprietary environmental technologies, equipment and specialty chemicals that enable coal-fueled boilers to meet emissions regulations. These solutions enhance existing air pollution control equipment, maximizing capacity and improving operating efficiencies. For more information, visit the company’s website at www.advancedemissionssolutions.com. About NetworkNewsWire…

Continue Reading

WednesdayMar 15, 2017 12:00 pm

Moleculin Biotech, Inc. (NASDAQ: MBRX) Starts Presentation at 29th Annual Roth Conference

Moleculin Biotech (NASDAQ: MBRX) is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukaemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas. For more information, visit the company’s website at www.moleculin.com.…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers